Ra Pharmaceuticals

Ra Pharma is developing Cyclomimetics, a new class of drugs that combines the diversity and specificity of antibodies with many of the advantages of small molecules. Ra Pharma is leveraging its ability to rapidly generate drug candidates to develop its own portfolio and partnerships, focusing on intracellular protein-protein interactions and other innovative approaches to address unmet medical needs.